NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Improved dosing schedule and decreased quantity per injection. -- the latter increasing dc migration.....in theory, but you knew that.

Even Dr. Bosch himself was pleasantly surprised at the apparent significant responses in the double rapid progressors and indeterminates, since they otherwise left these patients out of the phase III trial because researchers originally assumed they would not be significantly helped.

Ok, back to waiting for results in the phase iii trial.